|
|
||||||||
Journal of Applied Physiology, Vol 78, Issue 4 1319-1329, Copyright © 1995 by American Physiological Society
ARTICLES |
T. Ayuse, N. Brienza, J. P. Revelly, J. K. Boitnott and J. L. Robotham
Department of Anesthesiology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287-4965, USA.
The role of nitric oxide (NO) in the liver vasculature during baseline and endotoxic shock states was evaluated in 17 anesthetized pigs. Mean systemic arterial pressure, pulmonary arterial pressure, and portal venous pressure and flow, hepatic arterial pressure and flow, and cardiac output were measured. Pressure-flow (P-Q) relationships defined resistances as a back pressure and a slope. Inhibition of nitric oxide synthase (NOS) with NG-nitro-L-arginine methyl ester (L-NAME) at baseline increased mean arterial pressure, pulmonary arterial pressure, hepatic arterial pressure, and the slopes of their P-Q relationships (P < 0.05) but had no effect on portal venous pressure or its P-Q relationship. After endotoxin (10 micrograms/kg iv), NO induced arterial dilation and attenuated increases in portal venous and pulmonary arterial resistances (P < 0.05) that were reversed by L-NAME. NOS inhibition was stereospecifically reversed by L-arginine. Local control of liver blood flow at baseline via the hepatic arterial buffer response and hepatic arterial autoregulation were increased in gain after L-NAME. Endotoxic shock ablated the hepatic arterial buffer response and autoregulation independent of either NO or an alpha-adrenergic-receptor agonist (P < 0.05). Under baseline conditions, NO modulates pulmonary, systemic, and hepatic arterial but not portal venous resistances. NO production during endotoxic shock induces arterial hypotension and hepatic arterial vasodilation and attenuates increases in both portal and pulmonary resistances. NOS inhibition in endotoxic shock could increase morbidity due to a loss of local control of liver blood flow and marked increases in resistance to venous return across both the liver and lungs.
This article has been cited by other articles:
![]() |
B. Toth, Y. Yokoyama, J. F. Kuebler, M. G. Schwacha, L. W. Rue III, K. I. Bland, and I. H. Chaudry Sex Differences in Hepatic Heme Oxygenase Expression and Activity Following Trauma and Hemorrhagic Shock Arch Surg, December 1, 2003; 138(12): 1375 - 1382. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Moore, M. J. Burish, B. Farmer, D. W. Neal, C. Pan, and A. D. Cherrington Chronic hepatic artery ligation does not prevent liver from differentiating portal vs. peripheral glucose delivery Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E845 - E853. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Jakob Splanchnic Blood Flow in Low-Flow States Anesth. Analg., April 1, 2003; 96(4): 1129 - 1138. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tadros, D. L. Traber, and D. N. Herndon Trauma- and Sepsis-Induced Hepatic Ischemia and Reperfusion Injury: Role of Angiotensin II Arch Surg, July 1, 2000; 135(7): 766 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sato, A. Suzuki, Y. Nakajima, T. Iwamoto, H. Bito, and M. Miyabe S-nitroso-N-acetylpenicillamine (SNAP) During Hemorrhagic Shock Improves Mortality as a Result of Recovery From Vascular Hyporeactivity Anesth. Analg., February 1, 2000; 90(2): 362 - 362. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, P. Rogiers, N. Smail, A. Cabral, J.-C. Preiser, M.-O. Peny, and J.-L. Vincent Effects of nitric oxide on blood flow distribution and O2 extraction capabilities during endotoxic shock J Appl Physiol, October 1, 1997; 83(4): 1164 - 1173. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. ROSSELET, F. FEIHL, M. MARKERT, A. GNAEGI, C. PERRET, and L. LIAUDET Selective iNOS Inhibition Is Superior to Norepinephrine in the Treatment of Rat Endotoxic Shock Am. J. Respir. Crit. Care Med., January 1, 1997; 157(1): 162 - 170. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |